Table 1.
Demographics of COVID-19 adult participants that completed the Rand SF-36.
| Characteristics | Mean ± SD Frequency (%) |
|---|---|
| Age | 50.8 ± 16.6 |
| BMI * | 30.3 ± 7.9 |
| Normal or Underweight# | 20 (32.3%) |
| Overweight | 15 (24.2%) |
| Obese | 27(43.6%) |
| 15–44 Days Post PCR+ | 11 (18.0%) |
| 45–89 Days Post PCR+ | 16 (26.2%) |
| 90–175 Days Post PCR+ | 17 (27.9%) |
| 175+ Days Post PCR+ | 17 (27.9%) |
| Mean Days Post PCR+ | 125.3 ± 71.8 |
| Male | 24 (38.7%) |
| Female | 38 (61.3%) |
| Hispanic | 9 (14.5%) |
| Non-Hispanic | 53 (85.5%) |
| Hospitalized | 26 (42%) |
| Non-Hospitalized | 36 (58%) |
| Disease Severity | |
| Mild | 36 (58.1%) |
| Moderate | 12 (19.4%) |
| Severe | 14 (22.6%) |
| Post-Acute Sequelae COVID-19 (PASC) | 32 (51.6%) |
| No PASC | 30 (48.4%) |
| Pre-existing Medical Conditions | 28 (45.2%) |
| No Pre-Existing Conditions | 34 (54.8%) |
| Pre-existing Conditions | |
| Myocardial Infarction | 1 (1.6%) |
| CVA | 1 (1.6%) |
| COPD | 5 (8%) |
| Connective Tissue Disease | 1 (1.6%) |
| Liver Disease | 2 (3%) |
| DM | 11 (18%) |
| Lymphoma | 2 (3%) |
| HTN | 19 (31%) |
| Asthma | 11 (18%) |
Note: Disease severity was determined by oxygen use in accordance with the Yale Impact Score: mild (no oxygen required), moderate (1–5 L oxygen use), severe (<5 L oxygen use). Pre-existing conditions were collected from hospital electronic records and self-reported at clinic visits: CVA cerebrovascular accident, COPD chronic obstructive pulmonary disease, DM diabetes mellitus, HTN high blood pressure. Values are presented as mean ± standard deviation or frequency (percent). * BMI = Body Mass Index, PCR = polymerase chain reaction, PASC = post-acute sequelae of COVID-19; 3 participants were mildly underweight (BMIs = 18.8, 19.4, 19.9).